Form 8-K · Current report
L3Harris 8-K, filed Jul 29, 2026
- Filed
- CIK
- 0000202058
- Accession no.
- 0000202058-26-000054
Summary
L3Harris Technologies reported robust financial results for the second quarter of 2026, with revenue reaching $5.9 billion and a diluted earnings per share of $3.13. During the earnings call, CEO Christopher Kubasik noted the company's focus on execution, while the company also announced increased guidance for consolidated revenue and earnings per share for 2026.
Key points
- Q2 2026 revenue reached $5.9 billion, an 8% increase from the prior year.
- The total backlog increased to a record $42 billion, with orders reaching $7.3 billion in the quarter.
- L3Harris Technologies reported an operating margin of 11.1% and a diluted EPS of $3.13, up 28%.
- The company increased its 2026 guidance for both consolidated revenue and earnings per share.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On July 29, 2026, L3Harris Technologies, Inc. released its second quarter financial results in an earnings release. The earnings release announcing the second quarter financial results is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information contained in this Current Report on Form 8-K that is furnished under Item 2.02, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference into any filing under the…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.